|Dr. Yunge Cai||Exec. Chairman||N/A||N/A||1972|
|Mr. Chi Chun Tang||CFO & Exec. Director||7.49M||N/A||1962|
|Mr. Lianchen Yin||Chief Investment Officer & Exec. Director||6.03M||N/A||1966|
|Mr. Mingao Zhang||Chief Investment Officer & Exec. Director||6.07M||N/A||1968|
|Dr. Wei Zhao||CEO & Exec. Director||N/A||N/A||1971|
China Everbright Limited, through its subsidiaries, engages in the investment activities and provision of financial services in Hong Kong and Mainland China. The company invests in unlisted equity securities and/or equity derivatives, as well as in the start-up and development stage companies. It also focuses on long term equity investment in real estate, infrastructure, medical and healthcare, resources assets, manufacturing, technology, media, and telecom sectors. In addition, the company is involved in the private equity investment, pre-IPO financing, and structured financing for listed companies; and treasury management operations. Further, it provides a range of financial services, including asset management, investment management, and investment advisory services related to absolute return funds, bond funds, and equity funds, as well as offers secretarial, money lending, fund management, venture capital, leasing, and consultancy services. The company was founded in 1997 and is headquartered in Hong Kong. China Everbright Limited is a subsidiary of Honorich Holdings Limited.
China Everbright Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.